1962Canadian Journal of Biochemistry and PhysiologyRequires access

EXCRETION OF 4-AMINO-5-IMIDAZOLECARBOXAMIDE AND CREATINE:CREATININE RATIOS IN HUMAN AND MOUSE MUSCULAR DYSTROPHY

Edith G. McGeer, P. L. McGeer, James R. Miller, Douglas Derry, C. Nichol

Open publisher page 1 citations

Abstract

Excretion of creatine, creatinine, and 4-amino-5-imidazolecarboxamide (AIC) was studied in genetically determined muscular dystrophy in the human and mouse. The AIC excretion was normal in both affected humans and mice as compared with groups of comparably aged controls. The creatine-to-creatinine ratio for human muscular dystrophics was more than four times as great as for their unaffected siblings. Both normal and dystrophic mice showed a "creatinuria" as compared to humans. The creatine-to-creatinine ratio for dystrophic mice was significantly higher than the controls, but the difference was apparent only in the first 2 months of life.

About this research paper

What this paper is about

Excretion of creatine, creatinine, and 4-amino-5-imidazolecarboxamide (AIC) was studied in genetically determined muscular dystrophy in the human and mouse. The AIC excretion was normal in both affected humans and mice as compared with groups of comparably aged controls. The creatine-to-creatinine ratio for human muscular dystrophics was more than four times as great as for their unaffected siblings. Both normal and dystrophic mice showed a "creatinuria" as compared to humans. The creatine-to-creatinine ratio for dystrophic mice was significantly higher than the controls, but the difference was apparent only in the first 2 months of life.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Excretion of creatine, creatinine, and 4-amino-5-imidazolecarboxamide (AIC) was studied in genetically determined muscular dystrophy in the human and mouse. The AIC excretion was normal in both affected humans and mice as compared with groups of comparably aged controls. The creatine-to-creatinine ratio for human muscular dystrophics was more than four times as great as for their unaffected siblings. Both normal and dystrophic mice showed a "creatinuria" as compared to humans. The creatine-to-creatinine ratio for dystrophic mice was significantly higher than the controls, but the difference was apparent only in the first 2 months of life.

Key concepts: Creatine, Creatinine, Muscular dystrophy, Endocrinology, Internal medicine, Excretion, Chemistry, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
EXCRETION OF 4-AMINO-5-IMIDAZOLECARBOXAMIDE AND CREATINE:CREATININE RATIOS IN HUMAN AND MOUSE MUSCULAR DYSTROPHY — Research Paper | ScholarLens